SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PREM14A - Preliminary proxy statements relating to merger or acquisition:
SEC Accession No. 0001193125-24-096376
Filing Date
2024-04-15
Accepted
2024-04-15 17:18:30
Documents
5
Period of Report
2024-04-15

Document Format Files

Seq Description Document Type Size
1 PREM14A d752872dprem14a.htm PREM14A 1582948
2 EX-FILING FEES d752872dexfilingfees.htm EX-FILING FEES 16875
3 GRAPHIC g752872dsp001.jpg GRAPHIC 150101
4 GRAPHIC g752872dsp002.jpg GRAPHIC 132353
5 GRAPHIC g752872g42r61.jpg GRAPHIC 595728
  Complete submission text file 0001193125-24-096376.txt   2797349
Mailing Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060
Business Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060 540-818-2844
Landos Biopharma, Inc. (Filer) CIK: 0001785345 (see all company filings)

IRS No.: 815085535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PREM14A | Act: 34 | File No.: 001-39971 | Film No.: 24845481
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)